Journal of Clinical Oncology

BRCAPRO model underestimates BRCA1/2 mutation risk

(HealthDay)—Use of the BRCAPRO model for assessment of the likelihood of having a germline BRCA1/BRCA2 mutation, based on age, ethnicity, and family history, may underestimate the risk of mutations, ac ...

Mar 21, 2014
popularity not rated yet | comments 0

Experimental drug helps body fight advanced melanoma

(HealthDay)—An experimental drug that harnesses the power of the body's immune system to fight cancer has helped some patients with advanced melanoma keep their disease in check for several years, a new ...

Mar 03, 2014
popularity 4.6 / 5 (5) | comments 0